Loading...
ACI logo

Archean Chemical Industries LimitedNSEI:ACI Stock Report

Market Cap ₹64.4b
Share Price
₹521.50
₹600.33
13.1% undervalued intrinsic discount
1Y-16.8%
7D-6.9%
Portfolio Value
View

Archean Chemical Industries Limited

NSEI:ACI Stock Report

Market Cap: ₹64.4b

Archean Chemical Industries (ACI) Stock Overview

Manufactures and sells specialty marine chemicals in India and internationally. More details

ACI fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance2/6
Financial Health6/6
Dividends2/6

ACI Community Fair Values

Create Narrative

See what 53 others think this stock is worth. Follow their fair value or set your own to get alerts.

Archean Chemical Industries Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Archean Chemical Industries
Historical stock prices
Current Share Price₹521.50
52 Week High₹727.60
52 Week Low₹483.00
Beta0.32
1 Month Change-13.02%
3 Month Change-7.96%
1 Year Change-16.77%
3 Year Change-3.38%
5 Year Changen/a
Change since IPO13.83%

Recent News & Updates

Analysis Article May 16

Earnings Miss: Archean Chemical Industries Limited Missed EPS By 30% And Analysts Are Revising Their Forecasts

There's been a notable change in appetite for Archean Chemical Industries Limited ( NSE:ACI ) shares in the week since...

Recent updates

Analysis Article May 16

Earnings Miss: Archean Chemical Industries Limited Missed EPS By 30% And Analysts Are Revising Their Forecasts

There's been a notable change in appetite for Archean Chemical Industries Limited ( NSE:ACI ) shares in the week since...
Narrative Update Apr 27

ACI: Stable Outlook Will Reflect Leadership Changes And Subsidiary Merger

Analysts have kept their price target for Archean Chemical Industries broadly unchanged around ₹600. This reflects stable assumptions on fair value, discount rate, revenue growth, profit margin and future P/E, and signals that their core view on the stock remains intact.
Narrative Update Apr 12

ACI: Leadership Changes And Subsidiary Merger Will Shape A Balanced Outlook

Analysts have held their price target for Archean Chemical Industries broadly steady at around ₹600, with only marginal tweaks driven by slightly adjusted discount rate and P/E assumptions rather than any meaningful change in growth or margin expectations. What's in the News Board meeting scheduled on Feb 4, 2026 at 17:00 IST to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025, along with other matters (company filing).
Narrative Update Mar 28

ACI: Leadership Changes And Subsidiary Merger Will Guide A Measured Outlook

The analyst price target for Archean Chemical Industries is maintained at ₹600.33, with minor adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions leading analysts to refine rather than rebase their valuation views. What's in the News A board meeting is scheduled for Mar 19, 2026 at 16:00 IST to consider approving the merger of wholly owned subsidiary Idealis Chemicals Private Limited with wholly owned subsidiary Idealis Mudchemie Private Limited (company filing).
Narrative Update Mar 12

ACI: Leadership Proposals And Slightly Revised Assumptions Will Shape Balanced Outlook

Analysts now place Archean Chemical Industries' fair value at around ₹600, down from roughly ₹626. This reflects slightly lower profit margin assumptions and a modestly lower future P/E multiple, partly offset by steady views on revenue growth and risk.
Narrative Update Feb 25

ACI: Upcoming Meetings And Stable Assumptions Will Support Balanced Long Term Outlook

Analysts have maintained their fair value estimate for Archean Chemical Industries at about ₹626 per share, citing largely stable assumptions around the discount rate, revenue growth, profit margin, and future P/E in their updated price target analysis. What's in the News Board meeting scheduled for February 4, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (company filing).
Narrative Update Feb 10

ACI: Upcoming Results And Adjusted Assumptions Will Support Balanced Long Term Outlook

Analysts now see fair value for Archean Chemical Industries at ₹625.86, down from ₹654.43, citing updated views on discount rates, revenue growth, profit margins and future P/E assumptions. What's in the News Board meeting scheduled for February 4, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Key Developments).
Analysis Article Feb 08

Earnings Report: Archean Chemical Industries Limited Missed Revenue Estimates By 11%

Investors in Archean Chemical Industries Limited ( NSE:ACI ) had a good week, as its shares rose 2.5% to close at ₹580...
Narrative Update Jan 27

ACI: Upcoming Results Review Will Support Confident Long Term Bullish Outlook

Analysts have maintained their fair value estimate for Archean Chemical Industries at ₹654.43 per share, noting that only minor adjustments to inputs such as the discount rate, revenue growth, profit margin and future P/E assumptions were required, and these changes did not materially affect their overall view. What's in the News A board meeting is scheduled on Nov 14, 2025 at 16:30 Indian Standard Time to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended Sep 30, 2025 (company filing).
Narrative Update Jan 12

ACI: Upcoming Results Review And Steady Assumptions Will Support Bullish Outlook

Analysts have kept their price target for Archean Chemical Industries steady at ₹654.43, citing only modest tweaks to assumptions on discount rate, revenue growth, profit margin and future P/E that, in their view, do not materially change the story for the stock. What's in the News A board meeting is scheduled for November 14, 2025, at 16:30 Indian Standard Time to review and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Key Developments).
Narrative Update Dec 25

ACI: Upcoming Financial Review Will Support Bullish Long Term Outlook

Analysts have increased their price target on Archean Chemical Industries to ₹654.43 per share. This reflects a modest upward revision supported by slightly higher assumed future valuation multiples, which more than offset minor trims to revenue growth and margin expectations.
Narrative Update Dec 11

ACI: Upcoming Financial Review Will Support Bullish Long Term Outlook

Analysts have nudged their price target for Archean Chemical Industries slightly higher to reflect modest improvements in discount rate assumptions, along with sustained expectations for strong revenue growth, stable profit margins, and an attractive future P/E multiple, implying fair value of ₹654.43 per share. What's in the News Board meeting scheduled on November 14, 2025, at 16:30 IST to review and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing) Limited Review Report from statutory auditors on standalone and consolidated unaudited financial results to be considered by the board in the upcoming meeting (company filing) Unaudited financial results for the period ended September 30, 2025, are planned to be published in newspapers in line with SEBI LODR Regulation 47 requirements (company filing) Valuation Changes Discount Rate, edged down slightly from 13.47 percent to 13.44 percent, modestly increasing the present value of projected cash flows.
Narrative Update Nov 27

ACI: Upcoming Board Decision Will Drive Future Financial Momentum

Analysts have revised their price target for Archean Chemical Industries downward from ₹714.57 to ₹654.43, citing slightly lower forecasts for revenue growth and profit margins based on the latest review of fundamentals. What's in the News An upcoming board meeting is scheduled for November 14, 2025, at 16:30 IST to review and approve the un-audited financial results for the quarter and half year ended September 30, 2025 (Key Developments).
Analysis Article Nov 22

Archean Chemical Industries' (NSE:ACI) Shareholders Have More To Worry About Than Only Soft Earnings

Archean Chemical Industries Limited's ( NSE:ACI ) recent weak earnings report didn't cause a big stock movement...
Analysis Article Nov 20

What You Need To Know About The Archean Chemical Industries Limited (NSE:ACI) Analyst Downgrade Today

Market forces rained on the parade of Archean Chemical Industries Limited ( NSE:ACI ) shareholders today, when the...
Analysis Article Oct 10

Archean Chemical Industries (NSE:ACI) Will Want To Turn Around Its Return Trends

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Analysis Article Aug 28

Earnings Tell The Story For Archean Chemical Industries Limited (NSE:ACI)

When close to half the companies in India have price-to-earnings ratios (or "P/E's") below 27x, you may consider...
Analysis Article Aug 02

Archean Chemical Industries Limited Just Missed Earnings - But Analysts Have Updated Their Models

Archean Chemical Industries Limited ( NSE:ACI ) just released its latest first-quarter report and things are not...
Analysis Article May 09

Some May Be Optimistic About Archean Chemical Industries' (NSE:ACI) Earnings

Shareholders appeared unconcerned with Archean Chemical Industries Limited's ( NSE:ACI ) lackluster earnings report...
Analysis Article Apr 26

Archean Chemical Industries Limited (NSE:ACI) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable

Archean Chemical Industries Limited ( NSE:ACI ) shareholders would be excited to see that the share price has had a...
Analysis Article Apr 10

An Intrinsic Calculation For Archean Chemical Industries Limited (NSE:ACI) Suggests It's 21% Undervalued

Key Insights The projected fair value for Archean Chemical Industries is ₹732 based on 2 Stage Free Cash Flow to Equity...
Analysis Article Mar 12

Returns On Capital Are Showing Encouraging Signs At Archean Chemical Industries (NSE:ACI)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article Feb 15

What You Can Learn From Archean Chemical Industries Limited's (NSE:ACI) P/E After Its 29% Share Price Crash

To the annoyance of some shareholders, Archean Chemical Industries Limited ( NSE:ACI ) shares are down a considerable...
User avatar
New Narrative Jan 16

Diversifying Into High-Growth Sectors Like Semiconductors And Energy Storage Will Drive Future Growth

Archean invests in high-growth sectors like semiconductors and energy storage, diversifying its portfolio to drive future revenue growth.
Analysis Article Jan 13

Archean Chemical Industries (NSE:ACI) Has A Pretty Healthy Balance Sheet

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Dec 18

Estimating The Fair Value Of Archean Chemical Industries Limited (NSE:ACI)

Key Insights The projected fair value for Archean Chemical Industries is ₹713 based on 2 Stage Free Cash Flow to Equity...
Analysis Article Nov 16

The Consensus EPS Estimates For Archean Chemical Industries Limited (NSE:ACI) Just Fell Dramatically

The latest analyst coverage could presage a bad day for Archean Chemical Industries Limited ( NSE:ACI ), with the...
Analysis Article Jul 03

Archean Chemical Industries (NSE:ACI) Knows How To Allocate Capital Effectively

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...
Analysis Article May 22

Archean Chemical Industries Limited (NSE:ACI) Analysts Just Slashed This Year's Estimates

Market forces rained on the parade of Archean Chemical Industries Limited ( NSE:ACI ) shareholders today, when the...
Analysis Article May 03

Archean Chemical Industries Limited's (NSE:ACI) Shares Not Telling The Full Story

When close to half the companies in India have price-to-earnings ratios (or "P/E's") above 32x, you may consider...
Analysis Article Mar 18

Under The Bonnet, Archean Chemical Industries' (NSE:ACI) Returns Look Impressive

What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...
Analysis Article Feb 28

Calculating The Fair Value Of Archean Chemical Industries Limited (NSE:ACI)

Key Insights Archean Chemical Industries' estimated fair value is ₹907 based on 2 Stage Free Cash Flow to Equity...
Analysis Article Nov 28

We Like Archean Chemical Industries' (NSE:ACI) Returns And Here's How They're Trending

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
Analysis Article Nov 06

Cautious Investors Not Rewarding Archean Chemical Industries Limited's (NSE:ACI) Performance Completely

Archean Chemical Industries Limited's ( NSE:ACI ) price-to-earnings (or "P/E") ratio of 16.1x might make it look like a...

Shareholder Returns

ACIIN ChemicalsIN Market
7D-6.9%2.1%0.7%
1Y-16.8%-2.0%-0.3%

Return vs Industry: ACI underperformed the Indian Chemicals industry which returned -2% over the past year.

Return vs Market: ACI underperformed the Indian Market which returned -0.3% over the past year.

Price Volatility

Is ACI's price volatile compared to industry and market?
ACI volatility
ACI Average Weekly Movement5.6%
Chemicals Industry Average Movement7.2%
Market Average Movement7.2%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.8%

Stable Share Price: ACI has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: ACI's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003262Ranjit Pendurthiwww.archeanchemicals.com

Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for agrochemicals, medical, glass, cosmetics, and medical users industries. The company was founded in 2003 and is based in Chennai, India.

Archean Chemical Industries Limited Fundamentals Summary

How do Archean Chemical Industries's earnings and revenue compare to its market cap?
ACI fundamental statistics
Market cap₹64.38b
Earnings (TTM)₹1.07b
Revenue (TTM)₹10.81b
60.3x
P/E Ratio
6.0x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ACI income statement (TTM)
Revenue₹10.81b
Cost of Revenue₹642.67m
Gross Profit₹10.17b
Other Expenses₹9.10b
Earnings₹1.07b

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)8.66
Gross Margin94.06%
Net Profit Margin9.88%
Debt/Equity Ratio21.0%

How did ACI perform over the long term?

See historical performance and comparison

Dividends

0.5%
Current Dividend Yield
29%
Payout Ratio

Does ACI pay a reliable dividends?

See ACI dividend history and benchmarks
When do you need to buy ACI by to receive an upcoming dividend?
Archean Chemical Industries dividend dates
Ex Dividend DateJun 05 2026
Dividend Pay DateJul 11 2026
Days until Ex dividend15 days
Days until Dividend pay date51 days

Does ACI pay a reliable dividends?

See ACI dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/20 19:35
End of Day Share Price 2026/05/20 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Archean Chemical Industries Limited is covered by 8 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Archit Joshi360 ONE Capital Market Private Limited
null null360 ONE Capital Market Private Limited
Prathamesh MasdekarBP Wealth Management Private Limited